Showing results (461-470 of 552) with videos related to
Sort By:
Pageof 56
Viruses|September 27, 2025
Versatile and Scalable Nanoparticle Vaccine as a Scaffold Against Newly Emerging Influenza VirusesAlessandro Pardini, Dominik A Rothen, Pascal S Krenger, et al.Transplantation Proceedings|February 7, 2018
Late Steroid Withdrawal Following AB0-Incompatible Renal TransplantationF Bachmann, N Lachmann, K Budde, et al.Iscience|March 25, 2024
A tetravalent nanovaccine that inhibits growth of HPV-associated head and neck carcinoma via dendritic and T cell activationRomano Josi, Daniel E Speiser, Simone de Brot, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 20, 2009
Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trialG Senti, P Johansen, S Haug, et al.Vaccines|April 30, 2021
AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine CandidateXuelan Liu, Xinyue Chang, Dominik Rothen, et al.Science (New York, N.Y.)|June 2, 1995
Fibroblasts as efficient antigen-presenting cells in lymphoid organsT M Kündig, M F Bachmann, C DiPaolo, et al.European Journal of Immunology|September 1, 1994
Class II major histocompatibility complex-restricted T cell function in CD4-deficient miceA Rahemtulla, T M Kündig, A Narendran, et al.World Journal of Emergency Surgery : WJES|April 24, 2025
Management of acute mesenteric ischaemia in adult patients: a systematic review and meta-analysisAnnika Reintam Blaser, Merli Koitmäe, Kaspar F Bachmann, et al.The Journal of Allergy and Clinical Immunology|June 6, 2006
Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adultsThomas M Kündig, Gabriela Senti, Gabriel Schnetzler, et al.Journal of Virology|April 14, 2004
The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3Dominique Sirena, Benjamin Lilienfeld, Markus Eisenhut, et al.Pageof 56